BIOLOGÍA MOLECULAR Y CELULAR EN HEMOPATÍAS
Hospital Universitari de Tarragona Joan XXIII
Tarragona, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Universitari de Tarragona Joan XXIII (5)
2023
-
Impact of pre- and/or post-autologous stem cell transplantation exposure to brentuximab vedotin on survival outcomes in patients with high-risk Hodgkin lymphoma
Annals of Hematology, Vol. 102, Núm. 2, pp. 429-437
2011
-
Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens
Blood, Vol. 117, Núm. 6, pp. 1799-1805
2008
-
Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia: High response rate and disease eradication
Clinical Cancer Research, Vol. 14, Núm. 1, pp. 155-161
2007
2006
-
Analysis of dyslipidemia in patients on chronic hemodialysis in Catalonia
Atherosclerosis, Vol. 184, Núm. 1, pp. 94-102